Collagen-boosting TCM herb may hold the answer to preventing bone loss

c7e00bd1-7015-4177-9cb3-6e51c005e9fcarticleimage.jpg

30 Aug 2017 --- An herb used in Traditional Chinese medicine (TCM) might be crucial to a new osteoporosis therapy that could prevent bone loss without causing side effects, according to a new study by researchers at the University of British Columbia (UBC). 

Using a compound derived from red sage, known as Danshen in Chinese, UBC researchers have found a way to selectively block an enzyme called Cathepsin K (CatK), which plays a major role in the breakdown of collagen in bones during osteoporosis. The researchers’ findings have been published in the Journal of Bone and Mineral Research

Osteoporosis is a global health problem that will affect one out of three women and one out of five men worldwide, and there is a multibillion-dollar pharmaceutical industry dedicated to finding treatments to stop its progression, according to UBC’s press release.

“The development of osteoporosis drugs by pharmaceutical companies has focused heavily on blocking CatK in recent years,” says Dieter Brömme, a professor in the faculty of dentistry and a Canada Research Chair in Proteases and Disease of previous efforts. “All clinical trials to date have failed due to side effects ranging from stroke, skin fibrosis and cardiovascular issues. We've found a way to block CatK only in bone tissue that we think will prevent these other negative effects.”

Compound holds key
The researchers tested a compound derived from red sage in human and mouse bone cells and a mouse model. They found that it prevented bone loss and increased the bone mineral density of the mice treated with the compound by 35 percent when compared with the control group.

The study builds on previous research by Brömme and his team that looked at the effectiveness of red sage, used to treat bone ailments in traditional Chinese medicine, in stopping the activity of CatK in limited ways.

Enzyme blockers work like keys in locks, notes UBC’s press release. Most drugs in development have been so called active site-directed inhibitors, which act like master keys and lock the entire enzyme, blocking both its disease-relevant functions such as collagen degradation and its other normal functions.

“CatK is a multifunctional enzyme with important roles in other parts of the body and we think completely blocking it is what causes unexpected side effects in other drugs,” explains Preety Panwar, a research associate in the Brömme lab. “Our compound only locks the collagen-degrading CatK activity, preventing the unregulated breakdown of collagen in bones without any other negative impacts.”

The treatment could also potentially be used to treat a variety of other bone and cartilage diseases such as arthritis and certain bone cancers.

Related Articles

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

Bad for the heart: Lobby group slams retailers for high salt meals for Valentine’s Day 

14 Feb 2018 --- Top retailers are providing excessive salt, calories, saturated fat and sugars in their Valentine’s “dine-in” meal deals at bargain prices – that is the assertion from Consensus Action on Salt and Health (CASH), a campaign group concerned with salt and its effects on health. The UK organization has carried out a new survey that reveals high levels of salt “hidden” in Valentine’s Day meal deals on sale at some of Britain’s biggest supermarkets. 

Nutrition & Health News

Bioiberica: Convenience in formulation driving innovation in joint health

06 Feb 2018 --- The world’s older population continues to grow at an astounding rate. According to a report by the US’ Census Bureau, nearly 17 percent of the world’s population will be aged 65 and over by 2050, up from the current 8 percent. This aging of the population is reflected in a rising interest in age-related health aspects such as bone and joint health. Unsurprisingly maybe, mobility has also become a key area of focus as the loss of physical mobility that so often accompanies aging is the number one reason why many elderly people end up in nursing homes.

Nutrition & Health News

The US Council for Responsible Nutrition welcomes eight new companies as members

30 Jan 2018 --- The Council for Responsible Nutrition (CRN), a US trade association for the dietary supplement and functional food industry, has welcomed eight new companies to its membership ranks.

Nutrition & Health News

Herbal extracts (Part 2): Taking value from herbs – Driving innovation in the herbal space

29 Jan 2018 --- Herbal extracts continue to show great potential for innovation in the nutrition sector. The resurgence in the popularity of traditional medicine, which often has a "natural" image, is just one of the reasons why people are showing a renewed interest in products made with herbal content. In the second part of a special report, NutritionInsight looks at innovation and new ingredients within the herbal extracts space.

More Articles
URL : http://www.nutritioninsight.com:80/news/collagen-boosting-tcm-herb-may-hold-the-answer-to-preventing-bone-loss.html